HIMX [Himax Technologies] 6-K: Himax Announces Resignation of Chief Financial Officer TAINAN,

[Himax Announces Resignation of Chief Financial Officer TAINAN, Taiwan, Oct. 1, 2010 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. ("Himax" or the "Company") (Nasdaq:HIMX) today announced that Chief Financial Officer ("CFO") Max Chan has resigned from his position, effective immediately, to pursue a career opportunity with a private bio-tech company. The Board of Directors has begun the process of searching for] [FORM 6-K October 2010 000-51847 Himax Technologies, Inc. No.26, Zih Lian Road, Fonghua Village, Note: Note: Himax Technologies, Inc. Chief Financial Officer 6-K 1 document.htm FORM 6-K FILING DOCUMENT]

By | 2016-03-23T14:40:58+00:00 October 1st, 2010|Categories: Chinese Stocks, HIMX, Webplus ver|Tags: , , , , , |0 Comments

CCIH [ChinaCache International] 424B4: (Original Filing)

[ChinaCache International Holdings Ltd., or ChinaCache, is offering 5,014,100 American depositary shares, or ADSs, and the selling shareholders identified in this prospectus are offering an additional 1,046,880 ADSs. Each ADS represents 16 ordinary shares, par value US$0.0001 per share of ChinaCache. We will not receive any proceeds from the ADSs sold by the selling shareholders. Prior to this offering, there]

CCIH [ChinaCache International] 424B4: ChinaCache International Holdings Ltd., or ChinaCache, is offering

[ChinaCache International Holdings Ltd., or ChinaCache, is offering 5,014,100 American depositary shares, or ADSs, and the selling shareholders identified in this prospectus are offering an additional 1,046,880 ADSs. Each ADS represents 16 ordinary shares, par value US$0.0001 per share of ChinaCache. We will not receive any proceeds from the ADSs sold by the selling shareholders. Prior to this offering, there]

BSPM [Biostar Pharmaceuticals,] DEF 14A: (Original Filing)

[DEFINITIVEHEDULE 14A INFORMATION x o Check the appropriate box: o Preliminary Proxy Statement o x Definitive Proxy Statement o Definitiveditional Materials o BIOSTAR PHARMACEUTICALS, Payment of Filing Fee (Check the appropriate box): x No fee required. o Feemputed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.]

By | 2016-02-07T16:47:31+00:00 October 1st, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar